Ulsan Nam-gu Dermatology Clinic Maunja Prescription, Criteria to Know Before Starting Weight Loss Injections
5
Ulsan Nam-gu Dermatology Clinic: Guidelines to Know Before Starting Weight Loss Injections Prescribed by Maunja
If you have been on a diet for a long time, you may have experienced this at least once.
At first, weight decreases as you reduce your diet and increase your exercise, but over time, it becomes difficult to resist hunger or your meal portions increase again, causing weight to return.
Especially if you have repeatedly gone through multiple cycles of weight loss and regain, it is important to examine not just willpower but also your current weight, eating habits, and any accompanying health conditions.
Recently, many people have started considering medication as one of the methods for dieting by looking into the prescriptions from Ulsan Nam-gu Dermatology Clinic.
Maunja is a prescription medication containing terzepatide, which is approved in South Korea not only for type 2 diabetes but also for chronic weight management in adults who meet certain criteria for obesity or overweight.
However, it should not be approached merely as a cosmetic weight loss injection for the purpose of losing a few kilograms quickly. Korean Lilly also advises that the use for cosmetic purposes outside the approved indications and targets is not sanctioned.
Today, we will explore how Maunja is utilized for weight management and what aspects need to be checked before prescription.
1. What kind of medication is Maunzaro?
The main ingredient of Maunzaro is tirzepatide.
Compared to some well-known weight management injections, its distinctive feature is that it acts on two receptors, GIP and GLP-1, rather than just one receptor, making it a dual-action agent.
In simple terms, it is a medication designed to influence blood sugar control by acting on pathways related to hormones secreted after meals, while also regulating appetite and calorie intake to assist with chronic weight management.
Therefore, it is not accurate to simply understand Maunzaro as an 'injection that directly melts fat.'
Since it is a medication that affects signals related to meal quantity, satiety, and metabolism, it should be used considering not only current weight but also existing eating habits and health status.
2. The meaning of acting on both GLP-1 and GIP simultaneously
When searching for Maunzaro, you often come across the term GLP-1·GIP dual-action agent.
Both GLP-1 and GIP are related to incretin hormones that are involved in our body's metabolic processes after food intake.
Tirzepatide acts on these two receptors to promote insulin secretion in situations of high blood sugar and reduce glucagon secretion, while also influencing appetite and calorie intake regulation.
Therefore, using the medication may lead to a natural decrease in meal quantity or a prolonged feeling of fullness for some individuals.
However, it is important to note that receiving the injection does not automatically result in weight loss.
Even with the same medication, weight changes can vary among individuals depending on eating patterns, activity levels, starting weight, comorbidities, and responses to the medication.
3. Not everyone can be prescribed this
This is the first thing to check when looking for a prescription for Tirzepatide at Ulsan Nam-gu Dermatology.
Tirzepatide is not a general health supplement or a simple diet aid; it is a prescription medication that requires a doctor's consultation.
In South Korea, it is used according to approved criteria for obesity or overweight, so it should not be used arbitrarily by individuals of normal weight who wish to lose a few kilograms.
Before prescribing, it is generally necessary to check:
Current weight and BMI
Existing conditions
Medications currently being taken
Presence of diabetes
Previous diet experiences
Comorbidities related to weight
Personal and family medical history
It is necessary to verify these aspects.
In particular, it is not appropriate to apply the same dosage solely based on reasons like 'a friend used it and lost a lot of weight' or 'I saw good effects on social media.'
Who uses the medication is more important than anything else.
4. The dosage of the medication should not be started high from the beginning.
The medication is administered via subcutaneous injection once a week.
According to domestic product guidelines, for indications of obesity or overweight and type 2 diabetes, a starting dose of 2.5mg is used once a week for 4 weeks, followed by an increase to 5mg. If further dosage adjustment is needed, the current dose should be maintained for at least 4 weeks before gradually increasing by 2.5mg, with a maximum dose of 15mg once a week.
Why do we not use a high dose from the beginning?
Because the body needs to adapt to the medication.
Particularly, discomfort related to the gastrointestinal system may occur, so a gradual adjustment method is used while monitoring current reactions and tolerability.
Therefore, one should avoid arbitrarily increasing the dosage or reducing the administration interval to accelerate weight loss.
The dosage is determined by the medical staff, considering not only the degree of weight loss but also side effects and the patient's tolerability.
Particularly common adverse reactions include
Nausea
Diarrhea
Vomiting
Constipation
Dyspepsia
Abdominal discomfort
These are gastrointestinal symptoms.
The severity of symptoms may vary by individual, and discomfort may occur during the process of adjusting the dosage.
Additionally, special precautions may be necessary depending on existing conditions or medications, so it is important to accurately inform the medical staff of your health status before prescription.
If severe or persistent abnormal symptoms occur while using the medication, it is essential to consult with medical staff rather than simply tolerating and continuing use.
7. Mountazor Prescription FAQ
Q. How many times a week is Mountazor administered?
Generally, it is used as a subcutaneous injection once a week. It can be administered regardless of meal times, and it is important to use it according to the established schedule.
Q. Can I start with 5mg or 10mg from the beginning?
In the approved obesity and overweight dosage, treatment starts at 2.5mg and is gradually increased.
It is not appropriate to use a high dose from the beginning for rapid weight loss.
Q. Does taking Maunzaro suppress appetite?
It can affect appetite and calorie intake, but the degree of response varies from person to person.
This does not mean that you do not need to eat at all, and it is important to maintain a balanced nutritional intake.
Q. Can I stop taking it immediately once I reach my desired weight?
The duration of use and the timing of discontinuation of weight management medication should be determined based on individual treatment goals and responses.
Especially if dietary habits and activity levels are not managed after weight loss, weight may increase again, so it is advisable to establish a management plan for afterwards as well.
Q. Can I get a prescription just to lose 3-5kg for cosmetic purposes?
Maunzaro is a prescription medication used according to approved diseases and criteria in the country, and the manufacturer explicitly states that it is not approved for simple cosmetic weight loss purposes.
Therefore, the possibility of prescription must be confirmed through consultation considering current weight, BMI, and accompanying diseases.
